First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - MJM PHARMA CONSULTING LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: MJM PHARMA CONSULTING LIMITED, WEY COURT WEST, UNION ROAD, FARNHAM, SURREY, GU9 7PT. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 30 September 2017. The company was incorporated on 16 September 2016.

The accounts next due date is 31 December 2019. There are no mortgages.

The above was based on public record information as at 13 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 10378591
Date Incorporated: 16 September 2016
Date Latest Accounts: 30 September 2017
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 10378591
Annual Return: Unknown
Registered Office: WEY COURT WEST, UNION ROAD, FARNHAM, SURREY, GU9 7PT
SIC Code and Operations: 70229
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

MJM PHARMA CONSULTING LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 23 September 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
06342966 MJM PHOTOGRAPHY LIMITED Dissolved
12290095 MJM PLANNING LTD Active
15326018 MJM PLANNING SERVICES LIMITED Active
07824731 MJM PLANNING SOLUTIONS LIMITED Dissolved
14623599 MJM PLANT AND MACHINERY LIMITED Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd